Clinical utility of In-111 leukocyte imaging in Crohn's disease

F Navab1, C M Boyd

  • 1Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, USA.

Clinical Nuclear Medicine
|December 1, 1995
PubMed

Insights

In-111 leukocyte imaging aids in managing Crohn's disease, showing significant correlations between activity and disease presence. This diagnostic tool proved useful for immediate patient management, especially for those unable to undergo colonoscopy.

Area of Science:

  • Nuclear Medicine
  • Gastroenterology
  • Diagnostic Imaging

Background:

  • Crohn's disease is a chronic inflammatory bowel disease requiring accurate diagnostic tools.
  • Assessing disease activity and guiding management in Crohn's disease can be challenging.

Purpose of the Study:

  • To evaluate the utility of Indium-111 (In-111) leukocyte imaging in diagnosing and managing patients with Crohn's disease.
  • To determine the correlation between In-111 leukocyte imaging findings and disease presence.

Main Methods:

  • Thirty-six patients diagnosed with Crohn's disease underwent In-111 leukocyte imaging.
  • Imaging included early (4-hour) and delayed (18-24 hour) assessments for leukocyte activity.
  • Correlation analysis was performed on imaging results.

Main Results:

  • A significant correlation was observed between the presence of leukocyte activity on early imaging (r = 0.516, P < 0.001) and delayed imaging (r = 0.457, P < 0.003).
  • In-111 leukocyte imaging results were beneficial for the immediate management of 13 patients (36.1%).
  • This included four patients who refused colonoscopy and nine patients with prior intestinal resections.

Conclusions:

  • In-111 leukocyte imaging demonstrates a significant correlation with Crohn's disease activity.
  • This imaging modality is a valuable tool for immediate patient management, particularly in challenging cases.
  • It offers an alternative for patients unable or unwilling to undergo conventional endoscopic procedures.